QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in China 期刊论文 2019, 卷号: 9, 期号: 5, 页码: e028589 作者:  Jiang, Shiyu;  Liu, Peng;  Yang, Sheng;  Yang, Jianliang;  Wu, Dawei 收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03 cancer  clinical trials  patient satisfaction  stress   Promising efficacy of SHR-1210, a novel anti-programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China 期刊论文 2019, 卷号: 125, 期号: 5, 页码: 742-749 作者:  Huang, Jing;  Mo, Hongnan;  Zhang, Weilong;  Chen, Xuelian;  Qu, Dong 收藏  |  浏览/下载：21/0  |  提交时间：2020/01/03 B7-H1 antigen  DNA mismatch repair  l-lactate dehydrogenase  programmed cell death 1 receptor  stomach neoplasms   Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody 期刊论文 2019, 卷号: 10, 期号: 6, 页码: 1395-1401 作者:  Wang, Xi;  Zhang, Bo;  Chen, Xuelian;  Mo, Hongnan;  Wu, Dawei 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 Esophageal squamous cell carcinoma  immune checkpoint inhibitor  lactate dehydrogenase  markers  programmed cell death-1   Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210 期刊论文 2019, 卷号: 16, 期号: 1, 页码: 173-+ 作者:  Chen, Xuelian;  Ma, Lanying;  Wang, Xi;  Mo, Hongnan;  Wu, Dawei 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 Reactive capillary hemangiomas  SHR-1210  skin toxicity  anti-tumor efficacy